BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38212061)

  • 1. Food-derived compounds for CYP-phenotyping.
    Haschke M
    Br J Clin Pharmacol; 2024 Mar; 90(3):713-714. PubMed ID: 38212061
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
    Bosilkovska M; Samer C; Déglon J; Thomas A; Walder B; Desmeules J; Daali Y
    Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotyping for CYP 11D6 alleles.
    Synnott IH
    Aust N Z J Psychiatry; 1997 Jun; 31(3):431. PubMed ID: 9226092
    [No Abstract]   [Full Text] [Related]  

  • 4. Genotyping and phenotyping the cytochrome p-450 enzymes.
    Bachmann KA
    Am J Ther; 2002; 9(4):309-16. PubMed ID: 12115020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The basel cocktail for simultaneous phenotyping of human cytochrome P450 isoforms in plasma, saliva and dried blood spots.
    Donzelli M; Derungs A; Serratore MG; Noppen C; Nezic L; Krähenbühl S; Haschke M
    Clin Pharmacokinet; 2014 Mar; 53(3):271-282. PubMed ID: 24218006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 reaction-phenotyping: an industrial perspective.
    Zhang H; Davis CD; Sinz MW; Rodrigues AD
    Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):667-87. PubMed ID: 17916054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction phenotyping: current industry efforts to identify enzymes responsible for metabolizing drug candidates.
    Harper TW; Brassil PJ
    AAPS J; 2008; 10(1):200-7. PubMed ID: 18446520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high-throughput assay using liquid chromatography-tandem mass spectrometry for simultaneous in vivo phenotyping of 5 major cytochrome p450 enzymes in patients.
    Ghassabian S; Chetty M; Tattam BN; Chem MC; Glen J; Rahme J; Stankovic Z; Ramzan I; Murray M; McLachlan AJ
    Ther Drug Monit; 2009 Apr; 31(2):239-46. PubMed ID: 19307938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes.
    Rodrigues AD
    Biochem Pharmacol; 1999 Mar; 57(5):465-80. PubMed ID: 9952310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo?
    Tanaka E; Kurata N; Yasuhara H
    J Clin Pharm Ther; 2003 Jun; 28(3):157-65. PubMed ID: 12795773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous Determination of Cytochrome P450 Oxidation Capacity in Humans: A Review on the Phenotyping Cocktail Approach.
    de Andrés F; LLerena A
    Curr Pharm Biotechnol; 2016; 17(13):1159-1180. PubMed ID: 27677273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and phenotyping properties of the Basel phenotyping cocktail combination capsule in healthy male adults.
    Suenderhauf C; Berger B; Puchkov M; Schmid Y; Müller S; Huwyler J; Haschke M; Krähenbühl S; Duthaler U
    Br J Clin Pharmacol; 2020 Feb; 86(2):352-361. PubMed ID: 31657866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism of cytochrome P450 as a biomarker of susceptibility to environmental toxicity.
    Hong JY; Yang CS
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):759-62. PubMed ID: 9255558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo Phenotyping Methods: Cytochrome P450 Probes with Emphasis on the Cocktail Approach.
    Keller GA; Gago MLF; Diez RA; Di Girolamo G
    Curr Pharm Des; 2017; 23(14):2035-2049. PubMed ID: 28176665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous in vivo phenotyping of CYP enzymes.
    Ghassabian S; Murray M
    Methods Mol Biol; 2013; 987():261-7. PubMed ID: 23475684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: the CEIBA cocktail.
    de Andrés F; Sosa-Macías M; Lazalde-Ramos BP; Naranjo ME; Tarazona-Santos E; Llerena A;
    Drug Metabol Drug Interact; 2013; 28(3):135-46. PubMed ID: 23787463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved cytochrome P450 phenotyping cocktail with a simplified and highly sensitive UHPLC-MS/MS assay in human plasma.
    Eagles SK; Wang X; Gross AS; McLachlan AJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():122013. PubMed ID: 32050158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytochrome P450 phenotyping in cancer treatment.
    Dees EC; Watkins PB
    J Clin Oncol; 2005 Feb; 23(6):1053-5. PubMed ID: 15657406
    [No Abstract]   [Full Text] [Related]  

  • 19. A cytochrome P450 phenotyping cocktail causing unexpected adverse reactions in female volunteers.
    Pedersen RS; Damkier P; Christensen MM; Brosen K
    Eur J Clin Pharmacol; 2013 Dec; 69(12):1997-9. PubMed ID: 23917460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone thiol adduct formation in human liver microsomes: enzyme kinetics and reaction phenotyping.
    Gan J; Qu Q; He B; Shyu WC; Rodrigues AD; He K
    Drug Metab Lett; 2008 Aug; 2(3):184-9. PubMed ID: 19356091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.